...
首页> 外文期刊>Washington Drug Letter >Manufacturers Withdraw OTC Infant Cough and Cold Treatments
【24h】

Manufacturers Withdraw OTC Infant Cough and Cold Treatments

机译:制造商撤回OTC婴儿咳嗽和感冒药

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

As the FDA prepares for an upcoming joint Nonprescription Drugs Advisory Committee and Pediatric Advisory Committee meeting to discuss the safety of children's OTC cough and cold medications, several manufacturers promoting the products for use in children under 2 years of age are voluntarily withdrawing the drugs from the market, the Consumer Healthcare Products Association (CHPA) announced Oct. 11.
机译:在FDA准备召开即将举行的非处方药咨询委员会和儿科咨询委员会联合会议以讨论儿童OTC咳嗽和感冒药的安全性时,几家推广该产品供2岁以下儿童使用的制造商正在自愿从药品中撤出药品。市场,美国消费者保健产品协会(CHPA)于10月11日宣布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号